| Events subsequent to the period end |
| 22. |
EVENTS
SUBSEQUENT TO THE PERIOD END |
Events subsequent to the period end
The
directors are not aware of any significant matter or circumstance arising since the end of the year to date of this report that may materially
affect results of the company for the year reported or their financial position as at 31 March 2025.
CILO
CYBIN HOLDINGS LIMITED
Annual financial statements
for the year ended 31 March 2025
(Registration number
2022/320351/06)
Schedule
of profit or loss
DETAIL STATEMENT OF PROFIT OR LOSS
| Figures in Rand | |
| | |
2025 | | |
2024 | |
| Other operating expenses | |
| | | |
| | | |
| | |
| Advertising | |
| | | |
| (108,689) | | |
| - | |
| Audit fees | |
| 11 | | |
| (756,784) | | |
| (207,379) | |
| Bank charges | |
| | | |
| (1,487) | | |
| (1,487) | |
| Consulting fees | |
| | | |
| (385,000) | | |
| - | |
| Depreciation | |
| 11 | | |
| (358,933) | | |
| - | |
| Employee costs | |
| 17 | | |
| (2,707,685) | | |
| - | |
| Legal fees | |
| | | |
| - | | |
| (191,986) | |
| Municipal expenses | |
| | | |
| (2,525) | | |
| - | |
| Public relations and marketing | |
| | | |
| (127,785) | | |
| (163,413) | |
| Rent | |
| | | |
| (20,027) | | |
| - | |
| Secretarial fees | |
| | | |
| (300,000) | | |
| - | |
| Subscriptions | |
| | | |
| (211,239) | | |
| - | |
| Training and development | |
| | | |
| (32,666) | | |
| - | |
| Travel - local | |
| | | |
| (1,500) | | |
| - | |
| Travel – overseas | |
| | | |
| (83,315) | | |
| - | |
| Operating loss | |
| 10 | | |
| (5,097,635) | | |
| (564,265) | |
| Investment income | |
| 11 | | |
| 4,828,827 | | |
| 1,064,093 | |
| Finance costs | |
| 12 | | |
| (316,908) | | |
| (44,394) | |
| (Loss) profit for the year | |
| | | |
| (585,715) | | |
| 455,434 | |
CILO
CYBIN HOLDINGS LIMITED
Annual financial statements
for the year ended 31 March 2025
(Registration number
2022/320351/06)
SHAREHOLDER
INFORMATION
ALPS
and Dr Tham are the Controlling Shareholders of Cilo Cybin, and the table below gives a breakdown of Cilo Cybin Shareholders’ respective
holdings in the Company as at 31 March 2025.
Schedule
of shareholder information
| Shareholder | |
Directly
| | |
Indirectly | | |
Total
number of Shares | | |
% of total | |
| | |
| | |
| | |
| | |
| |
| Dr Tham1 | |
| 28,762,252 | | |
| - | | |
| 28,762,252 | | |
| 40.5 | % |
| ALPS Global Holding Berhad | |
| 28,762,252 | | |
| - | | |
| 28,762,252 | | |
| 40.5 | % |
| Gabriel Theron1 | |
| 3,550,895 | | |
| - | | |
| 3,550,895 | | |
| 5.00 | % |
| Shyan & Van Huyssteen | |
| 2,840,716 | | |
| - | | |
| 2,840,716 | | |
| 4.00 | % |
| Public | |
| 7,101,791 | | |
| - | | |
| 7,101,791 | | |
| 10.00 | % |
| Total | |
| 71,017,906 | | |
| - | | |
| 71,017,906 | | |
| 100.0 | % |
Note:
| |
1. |
Dr
Tham and Gabriel Theron are the only directors of the Company with an equity interest in the Company. |
An
analysis of ordinary shareholders in the Company as at 31 March 2025 is set out below:
Schedule
of analysis of ordinary shareholders
| Shareholder spread | |
Number of shareholders | | |
% of total shareholdings | | |
Number of shares | | |
% of issued capital | |
| 1 - 1 000 | |
| 932 | | |
| 72 | % | |
| 203,990 | | |
| 0 | % |
| 1 001 - 10 000 | |
| 244 | | |
| 19 | % | |
| 896,181 | | |
| 1 | % |
| 10 001 - 100 000 | |
| 93 | | |
| 7 | % | |
| 3,332,163 | | |
| 5 | % |
| 1 00 001 - 1 000 000 | |
| 13 | | |
| 1 | % | |
| 2,669,457 | | |
| 4 | % |
| Over 1 000 000 | |
| 4 | | |
| 0 | % | |
| 63,916,115 | | |
| 90 | % |
| Total | |
| 1,286 | | |
| 100 | % | |
| 71,017,906 | | |
| 100 | % |
| Distribution of shareholders | |
Number of shareholders | | |
% of total shareholdings | | |
Number of shares | | |
% of issued capital | |
| Retail Shareholders | |
| 1,282 | | |
| 100 | % | |
| 7,101,791 | | |
| 10 | % |
| Directors and Prescribed Officers | |
| 2 | | |
| 0 | % | |
| 32,313,147 | | |
| 45 | % |
| Strategic Shareholders | |
| 1 | | |
| 0 | % | |
| 28,762,252 | | |
| 41 | % |
| Promoters | |
| 1 | | |
| 0 | % | |
| 2,840,716 | | |
| 4 | % |
| Total | |
| 1,286 | | |
| 100 | % | |
| 71,017,906 | | |
| 100 | % |
MAJOR
SHAREHOLDERS
| Beneficial Shareholders with a holding of greater than 5% of the issued shares | |
Number of shares | | |
% of issued capital | |
| Dr Tham | |
| 28,762,252 | | |
| 41 | % |
| ALPS Global Holding Berhad | |
| 28,762,252 | | |
| 41 | % |
| Gabriel Theron | |
| 3,550,895 | | |
| 5 | % |
| Total | |
| 61,075,399 | | |
| 87 | % |
|
18.
EVENTS SUBSEQUENT TO THE PERIOD END.
Events subsequent to the period end
Subsequent
to year end, 7,101,791 ordinary shares were issued following completion of the subscription process associated with the IPO. Other than
the matter noted above, the directors are not aware of any material event which occurred after the reporting date and up to the date
of this report.
CILO
CYBIN HOLDINGS LIMITED
Annual
financial statements for the year ended 31 March 2024
(Registration
number 2022/320351/06)
SHAREHOLDER
INFORMATION
ALPS
and Dr Tham are the Controlling Shareholders of Cilo Cybin, and the table below gives a breakdown of Cilo Cybin Shareholders’ respective
holdings in the Company as at 31 March 2024:
Schedule
of shareholder information
Shareholder | |
| | |
Total
number of Shares | | |
%
of total | |
| | |
Directly | | |
Indirectly | | |
| | |
| |
| Dr Tham1 | |
| 28,762,252 | | |
| - | | |
| 28,762,252 | | |
| 45 | % |
| ALPS | |
| 28,762,252 | | |
| - | | |
| 28,762,252 | | |
| 45 | % |
| Gabriel Theron1 | |
| 3,550,895 | | |
| - | | |
| 3,550,895 | | |
| 5.56 | % |
| Shyan & Van Huyssteen | |
| 2,840,716 | | |
| - | | |
| 2,840,716 | | |
| 4.44 | % |
| Total | |
| 63,916,115 | | |
| - | | |
| 63,916,115 | | |
| 100.0 | % |
Note:
| 1. | Dr
Tham and Gabriel Theron are the only directors of the Company with an equity interest in
the Company. There were no changes to the number of shares held by Dr Tham or Gabriel Theron
between the year-end as at 31 March 2024 and the date of the approval of the annual financial
statements. |
| 2. | 7,101,791 Shares issued to members of the Public in terms of the successful IPO after year
ending 31 March 2024. |
DETAIL
STATEMENT OF PROFIT OR LOSS
Schedule
of profit or loss
| |
|
Notes | |
| 12
months ended 31
March 2024 | | |
| 12
months ended 31
March 2023 | |
| |
|
| |
| | | |
| | |
| Revenue |
|
| |
| - | | |
| - | |
| Cost of sales |
|
| |
| - | | |
| - | |
| Gross
profit |
|
| |
| - | | |
| - | |
| Other income |
|
| |
| - | | |
| - | |
| Investment revenue |
|
| |
| 1,064,093 | | |
| - | |
| Audit fees |
|
| |
| (207,379) | | |
| (70,000) | |
| Legal fees |
|
| |
| (191,986) | | |
| (104,163) | |
| Public relations and marketing |
|
| |
| (163,413) | | |
| (337,220) | |
| Secretarial services |
|
| |
| - | | |
| (26,532) | |
| Bank charges |
|
| |
| (1,487) | | |
| (2,089) | |
| Operating
loss |
|
| |
| 499,829 | | |
| (540,004) | |
| Finance cost |
|
| |
| (44,394) | | |
| (12,000) | |
| Profit / (Loss) before taxation |
|
| |
| 455,435 | | |
| (552,004) | |
| Taxation |
|
| |
| - | | |
| - | |
| Profit / (Loss) for the
year |
|
| |
| 455,435 | | |
| (552,004) | |
| Other comprehensive income |
|
| |
| - | | |
| - | |
| Total
comprehensive profit / (loss) |
|
| |
| 455,435 | | |
| (552,004) | |
|